カテゴリー： 世界, 医療/バイオ, Allied Market Research

痛みパッチの世界市場2021-2031：機会分析・産業予測

【英語タイトル】Pain Patch Market By Product Type (Non-Opioid Patches, Opioid Patches), By Type (Prescription Medicines, OTC Medicines), By Distribution Channel (Hospital Pharmacies, Drug Stores and Retail Pharmacies, Online Providers): Global Opportunity Analysis and Industry Forecast, 2021-2031

Allied Market Researchが出版した調査資料（ALD23JUN074）・商品コード：ALD23JUN074
・発行会社（調査会社）：Allied Market Research
・発行日：2023年3月
・ページ数：374
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール（受注後24時間以内）
・調査対象地域：グローバル
・産業分野：医療機器
◆販売価格オプション（消費税別）
Online Only（1名閲覧、印刷不可）USD3,570 ⇒換算￥542,640見積依頼/購入/質問フォーム
Single User（1名閲覧）USD5,730 ⇒換算￥870,960見積依頼/購入/質問フォーム
Enterprise User（閲覧人数無制限）USD9,600 ⇒換算￥1,459,200見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・送付（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
❖ レポートの概要 ❖

アライドマーケットリサーチ社の市場調査レポートでは、世界の痛みパッチ市場規模が、2021年の4,803.70百万ドルから2031年には7,338.07百万ドルまで拡大し、2022年から2031年までの予測期間中、年平均成長率は4.3％を記録すると推測されています。当レポートでは、痛みパッチの世界市場について多面的に調査・分析を行い、イントロダクション、エグゼクティブサマリー、市場概要、製品種類別（非オピオイドパッチ、オピオイドパッチ）分析、種類別（処方薬、OTC医薬品）分析、流通チャネル別（病院薬局、ドラッグストア・小売薬局、オンラインプロバイダー）分析、地域別（北米、ヨーロッパ、アジア太平洋、中南米/中東・アフリカ）分析、競争状況、企業情報などの内容を整理しています。なお、記載されている企業情報には、NEXGEL Advanced Hydrogel Solutions、Viatris Inc.、Johnson and Johnson、Teva Pharmaceutical Industries Ltd.、Sorrento Therapeutics Inc.、Hisamitsu Pharmaceutical Co.,Inc.、Endo International plc.、Purdue Pharma L.P.、Amneal Pharmaceuticals LLC、Grunenthalなどが含まれています。
・イントロダクション
・エグゼクティブサマリー
・市場概要
・世界の痛みパッチ市場規模：製品種類別
- 非オピオイドパッチの市場規模
- オピオイドパッチの市場規模
・世界の痛みパッチ市場規模：種類別
- 処方薬における市場規模
- OTC医薬品における市場規模
・世界の痛みパッチ市場規模：流通チャネル別
- 病院薬局チャネルの市場規模
- ドラッグストア・小売薬局チャネルの市場規模
- オンラインプロバイダーチャネルの市場規模
・世界の痛みパッチ市場規模：地域別
- 北米の痛みパッチ市場規模
- ヨーロッパの痛みパッチ市場規模
- アジア太平洋の痛みパッチ市場規模
- 中南米/中東・アフリカの痛みパッチ市場規模
・競争状況
・企業情報

痛みパッチ市場は2021年に48億370万ドルと評価され、2031年には73億3807万ドルに達すると推定されています。2022年から2031年までの年平均成長率は4.3%となる見込みです。

痛みパッチは経皮吸収型の鎮痛方法で、皮膚に薬剤を塗布し、皮膚から血流に吸収されます。これらのパッチは、一定期間にわたって薬剤を連続的に制御放出するように設計されており、痛みを効果的に管理するのに役立ちます。通常、関節炎、腰痛、神経障害性疼痛など、継続的な治療が必要な慢性疼痛に使用されます。薬は、フェンタニルやブプレノルフィンなどのオピオイドか、リドカインやジクロフェナクなどの非オピオイドのいずれかになります。これらのほとんどは処方箋のみで入手可能ですが、OTC（一般用医薬品）としても入手可能です。
痛みパッチ市場の原動力は、老人人口の増加、痛みパッチの使用量の増加、慢性疼痛の有病率の増加です。例えば、U.S. Pain Foundation 2022のレポートによると、毎年5000万人が慢性疼痛に苦しんでいます。したがって、慢性疼痛の有病率の増加は、市場の成長を促進することが期待されます。また、老年人口は関節痛、神経障害性疼痛、その他の慢性疼痛に悩まされる傾向があります。そのため、高齢者人口の増加が市場成長の原動力になる可能性があります。

さらに、疼痛管理のための先進的な方法に関連する意識の高まりや、サリチル酸メチルやニトログリセリンのようなOTC痛みパッチ製品の利用可能性は、市場の成長を後押しすると予測されています。また、パッチ技術の進歩も市場の成長を後押しすると予測されています。さらに、多くの主要企業が、世界の痛みパッチ市場における存在感を高めるために、協業、事業拡大、提携などの重要な戦略を採用しています。例えば、2022年8月、Sorrento Therapeutics Inc.は、ZTlido（リドカイン外用システム）が最大手の全国薬局給付管理者（PBM）の1つと国民健康保険制度に追加されることを発表しました。このような事業拡大が市場の成長を牽引すると期待されています。
しかし、鍼治療、理学療法、カイロプラクティックなどの代替治療が利用可能であることなどが、痛みパッチ市場の成長を抑制すると予測されています。また、オピオイド含有鎮痛パッチの製造・販売に関連する厳しい政府規制が市場の成長を妨げると予測されています。

痛みパッチ市場は、治療クラス、種類、流通チャネル、地域に区分されます。
治療クラス別では、市場は非オピオイドとオピオイドに二分されます。非オピオイドセグメントはさらに、非ステロイド性抗炎症薬（NSAIDS）、サリチル酸メチル、リドカイン、その他に分類されます。オピオイドセグメントはさらに、ブプレノルフィンとフェンタニルに分類されます。
種類別では、市場は医療用医薬品とOTC医薬品に分類されます。
流通チャネル別では、病院薬局、ドラッグストア、小売薬局、オンラインプロバイダーに分類されます。
地域別では、北米（米国、カナダ、メキシコ）、欧州（ドイツ、フランス、英国、イタリア、スペイン、その他の欧州地域）、アジア太平洋地域（日本、中国、オーストラリア、インド、韓国、その他のアジア太平洋地域）、LAMEA（ブラジル、南アフリカ、サウジアラビア、その他のLAMEA地域）に区分して分析しています。

世界の痛みパッチ市場で事業を展開する主な主要企業は、NEXGEL Advanced Hydrogel Solutions、Viatris Inc.、Johnson & Johnson、Teva Pharmaceutical Industries Ltd.、Sorrento Therapeutics Inc.、久光製薬株式会社、Endo International plc.、Purdue Pharma L.P.、Amneal Pharmaceuticals LLC、Grunenthalなどです。

〈ステークホルダーにとっての主なメリット〉
・本レポートは、2021年から2031年までの痛みパッチ市場分析の市場セグメント、現在の動向、予測、ダイナミクスを定量的に分析し、痛みパッチ市場の有力な機会を特定します。
・主な促進要因、阻害要因、機会に関する情報とともに市場調査を提供します。
・ポーターのファイブフォース分析により、バイヤーとサプライヤーの潜在力を明らかにし、ステークホルダーが利益重視のビジネス決定を下し、サプライヤーとバイヤーのネットワークを強化できるようにします。
・痛みパッチ市場のセグメンテーションを詳細に分析することで、市場機会を見極めることができます。
・各地域の主要国を世界市場への収益貢献度に応じてマッピングしています。
・市場プレイヤーのポジショニングはベンチマーキングを容易にし、市場プレイヤーの現在のポジションを明確に理解することができます。
・痛みパッチの地域別および世界市場動向、主要企業、市場セグメント、応用分野、市場成長戦略の分析を含みます。

〈主要市場セグメント〉
製品タイプ別
非オピオイドパッチ
医薬品
非ステロイド性抗炎症薬
サリチル酸メチル
リドカイン
その他
オピオイドパッチ
医薬品
ブプレノルフィン
フェンタニル

種類別
処方薬
一般用医薬品

流通チャネル別
病院薬局
ドラッグストア・薬局
オンラインプロバイダー

地域別
・北米
米国
カナダ
メキシコ
・ヨーロッパ
ドイツ
フランス
イギリス
イタリア
スペイン
その他のヨーロッパ
・アジア太平洋
日本
中国
インド
オーストラリア
韓国
・LAMEA
ブラジル
サウジアラビア
南アフリカ
その他のLAMEA地域

〈主要市場プレイヤー〉
NEXGEL Advanced Hydrogel Solutions
Viatris Inc.
Johnson and Johnson
Teva Pharmaceutical Industries Ltd.
Sorrento Therapeutics Inc.
久光製薬株式会社
Endo International plc.
Purdue Pharma L.P.
Amneal Pharmaceuticals LLC
Grunenthal

グローバル市場調査レポート販売サイトのwww.marketreport.jpです。

❖ レポートの目次 ❖

CHAPTER 1: INTRODUCTION
1.1. Report description
1.2. Key market segments
1.3. Key benefits to the stakeholders
1.4. Research Methodology
1.4.1. Primary research
1.4.2. Secondary research
1.4.3. Analyst tools and models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. CXO Perspective
CHAPTER 3: MARKET OVERVIEW
3.1. Market definition and scope
3.2. Key findings
3.2.1. Top impacting factors
3.2.2. Top investment pockets
3.3. Porter’s five forces analysis
3.3.1. Bargaining power of suppliers
3.3.2. Bargaining power of buyers
3.3.3. Threat of substitutes
3.3.4. Threat of new entrants
3.3.5. Intensity of rivalry
3.4. Market dynamics
3.4.1. Drivers
3.4.1.1. Technological advancement in pain patches
3.4.1.2. Rise in prevalence of Chronic Pain
3.4.1.3. Rising adoption of pain patch for pain management

3.4.2. Restraints
3.4.2.1. Availability of alternate treatments
3.4.2.2. Stringent government regulations

3.4.3. Opportunities
3.4.3.1. Growth opportunities in emerging markets

3.5. COVID-19 Impact Analysis on the market
CHAPTER 4: PAIN PATCH MARKET, BY PRODUCT TYPE
4.1. Overview
4.1.1. Market size and forecast
4.2. Non-Opioid Patches
4.2.1. Key market trends, growth factors and opportunities
4.2.2. Market size and forecast, by region
4.2.3. Market share analysis by country
4.2.4. Non-Opioid Patches Pain Patch Market by Drugs
4.3. Opioid Patches
4.3.1. Key market trends, growth factors and opportunities
4.3.2. Market size and forecast, by region
4.3.3. Market share analysis by country
4.3.4. Opioid Patches Pain Patch Market by Drugs
CHAPTER 5: PAIN PATCH MARKET, BY TYPE
5.1. Overview
5.1.1. Market size and forecast
5.2. Prescription Medicines
5.2.1. Key market trends, growth factors and opportunities
5.2.2. Market size and forecast, by region
5.2.3. Market share analysis by country
5.3. OTC Medicines
5.3.1. Key market trends, growth factors and opportunities
5.3.2. Market size and forecast, by region
5.3.3. Market share analysis by country
CHAPTER 6: PAIN PATCH MARKET, BY DISTRIBUTION CHANNEL
6.1. Overview
6.1.1. Market size and forecast
6.2. Hospital Pharmacies
6.2.1. Key market trends, growth factors and opportunities
6.2.2. Market size and forecast, by region
6.2.3. Market share analysis by country
6.3. Drug Stores and Retail Pharmacies
6.3.1. Key market trends, growth factors and opportunities
6.3.2. Market size and forecast, by region
6.3.3. Market share analysis by country
6.4. Online Providers
6.4.1. Key market trends, growth factors and opportunities
6.4.2. Market size and forecast, by region
6.4.3. Market share analysis by country
CHAPTER 7: PAIN PATCH MARKET, BY REGION
7.1. Overview
7.1.1. Market size and forecast By Region
7.2. North America
7.2.1. Key trends and opportunities
7.2.2. Market size and forecast, by Product Type
7.2.3. Market size and forecast, by Type
7.2.4. Market size and forecast, by Distribution Channel
7.2.5. Market size and forecast, by country
7.2.5.1. U.S.
7.2.5.1.1. Key market trends, growth factors and opportunities
7.2.5.1.2. Market size and forecast, by Product Type
7.2.5.1.3. Market size and forecast, by Type
7.2.5.1.4. Market size and forecast, by Distribution Channel
7.2.5.2. Canada
7.2.5.2.1. Key market trends, growth factors and opportunities
7.2.5.2.2. Market size and forecast, by Product Type
7.2.5.2.3. Market size and forecast, by Type
7.2.5.2.4. Market size and forecast, by Distribution Channel
7.2.5.3. Mexico
7.2.5.3.1. Key market trends, growth factors and opportunities
7.2.5.3.2. Market size and forecast, by Product Type
7.2.5.3.3. Market size and forecast, by Type
7.2.5.3.4. Market size and forecast, by Distribution Channel
7.3. Europe
7.3.1. Key trends and opportunities
7.3.2. Market size and forecast, by Product Type
7.3.3. Market size and forecast, by Type
7.3.4. Market size and forecast, by Distribution Channel
7.3.5. Market size and forecast, by country
7.3.5.1. Germany
7.3.5.1.1. Key market trends, growth factors and opportunities
7.3.5.1.2. Market size and forecast, by Product Type
7.3.5.1.3. Market size and forecast, by Type
7.3.5.1.4. Market size and forecast, by Distribution Channel
7.3.5.2. France
7.3.5.2.1. Key market trends, growth factors and opportunities
7.3.5.2.2. Market size and forecast, by Product Type
7.3.5.2.3. Market size and forecast, by Type
7.3.5.2.4. Market size and forecast, by Distribution Channel
7.3.5.3. UK
7.3.5.3.1. Key market trends, growth factors and opportunities
7.3.5.3.2. Market size and forecast, by Product Type
7.3.5.3.3. Market size and forecast, by Type
7.3.5.3.4. Market size and forecast, by Distribution Channel
7.3.5.4. Italy
7.3.5.4.1. Key market trends, growth factors and opportunities
7.3.5.4.2. Market size and forecast, by Product Type
7.3.5.4.3. Market size and forecast, by Type
7.3.5.4.4. Market size and forecast, by Distribution Channel
7.3.5.5. Spain
7.3.5.5.1. Key market trends, growth factors and opportunities
7.3.5.5.2. Market size and forecast, by Product Type
7.3.5.5.3. Market size and forecast, by Type
7.3.5.5.4. Market size and forecast, by Distribution Channel
7.3.5.6. Rest of Europe
7.3.5.6.1. Key market trends, growth factors and opportunities
7.3.5.6.2. Market size and forecast, by Product Type
7.3.5.6.3. Market size and forecast, by Type
7.3.5.6.4. Market size and forecast, by Distribution Channel
7.4. Asia-Pacific
7.4.1. Key trends and opportunities
7.4.2. Market size and forecast, by Product Type
7.4.3. Market size and forecast, by Type
7.4.4. Market size and forecast, by Distribution Channel
7.4.5. Market size and forecast, by country
7.4.5.1. Japan
7.4.5.1.1. Key market trends, growth factors and opportunities
7.4.5.1.2. Market size and forecast, by Product Type
7.4.5.1.3. Market size and forecast, by Type
7.4.5.1.4. Market size and forecast, by Distribution Channel
7.4.5.2. China
7.4.5.2.1. Key market trends, growth factors and opportunities
7.4.5.2.2. Market size and forecast, by Product Type
7.4.5.2.3. Market size and forecast, by Type
7.4.5.2.4. Market size and forecast, by Distribution Channel
7.4.5.3. India
7.4.5.3.1. Key market trends, growth factors and opportunities
7.4.5.3.2. Market size and forecast, by Product Type
7.4.5.3.3. Market size and forecast, by Type
7.4.5.3.4. Market size and forecast, by Distribution Channel
7.4.5.4. Australia
7.4.5.4.1. Key market trends, growth factors and opportunities
7.4.5.4.2. Market size and forecast, by Product Type
7.4.5.4.3. Market size and forecast, by Type
7.4.5.4.4. Market size and forecast, by Distribution Channel
7.4.5.5. South Korea
7.4.5.5.1. Key market trends, growth factors and opportunities
7.4.5.5.2. Market size and forecast, by Product Type
7.4.5.5.3. Market size and forecast, by Type
7.4.5.5.4. Market size and forecast, by Distribution Channel
7.4.5.6. Rest of Asia-Pacific
7.4.5.6.1. Key market trends, growth factors and opportunities
7.4.5.6.2. Market size and forecast, by Product Type
7.4.5.6.3. Market size and forecast, by Type
7.4.5.6.4. Market size and forecast, by Distribution Channel
7.5. LAMEA
7.5.1. Key trends and opportunities
7.5.2. Market size and forecast, by Product Type
7.5.3. Market size and forecast, by Type
7.5.4. Market size and forecast, by Distribution Channel
7.5.5. Market size and forecast, by country
7.5.5.1. Brazil
7.5.5.1.1. Key market trends, growth factors and opportunities
7.5.5.1.2. Market size and forecast, by Product Type
7.5.5.1.3. Market size and forecast, by Type
7.5.5.1.4. Market size and forecast, by Distribution Channel
7.5.5.2. Saudi Arabia
7.5.5.2.1. Key market trends, growth factors and opportunities
7.5.5.2.2. Market size and forecast, by Product Type
7.5.5.2.3. Market size and forecast, by Type
7.5.5.2.4. Market size and forecast, by Distribution Channel
7.5.5.3. South Africa
7.5.5.3.1. Key market trends, growth factors and opportunities
7.5.5.3.2. Market size and forecast, by Product Type
7.5.5.3.3. Market size and forecast, by Type
7.5.5.3.4. Market size and forecast, by Distribution Channel
7.5.5.4. Rest of LAMEA
7.5.5.4.1. Key market trends, growth factors and opportunities
7.5.5.4.2. Market size and forecast, by Product Type
7.5.5.4.3. Market size and forecast, by Type
7.5.5.4.4. Market size and forecast, by Distribution Channel
CHAPTER 8: COMPETITIVE LANDSCAPE
8.1. Introduction
8.2. Top winning strategies
8.3. Product Mapping of Top 10 Player
8.4. Competitive Dashboard
8.5. Competitive Heatmap
8.6. Top player positioning, 2021
CHAPTER 9: COMPANY PROFILES
9.1. Viatris Inc.
9.1.1. Company overview
9.1.2. Key Executives
9.1.3. Company snapshot
9.1.4. Operating business segments
9.1.5. Product portfolio
9.1.6. Business performance
9.2. Johnson and Johnson
9.2.1. Company overview
9.2.2. Key Executives
9.2.3. Company snapshot
9.2.4. Operating business segments
9.2.5. Product portfolio
9.2.6. Business performance
9.3. Teva Pharmaceutical Industries Ltd.
9.3.1. Company overview
9.3.2. Key Executives
9.3.3. Company snapshot
9.3.4. Operating business segments
9.3.5. Product portfolio
9.3.6. Business performance
9.3.7. Key strategic moves and developments
9.4. Hisamitsu Pharmaceutical Co.,Inc.
9.4.1. Company overview
9.4.2. Key Executives
9.4.3. Company snapshot
9.4.4. Operating business segments
9.4.5. Product portfolio
9.4.6. Business performance
9.4.7. Key strategic moves and developments
9.5. Endo International plc.
9.5.1. Company overview
9.5.2. Key Executives
9.5.3. Company snapshot
9.5.4. Operating business segments
9.5.5. Product portfolio
9.5.6. Business performance
9.6. NEXGEL Advanced Hydrogel Solutions
9.6.1. Company overview
9.6.2. Key Executives
9.6.3. Company snapshot
9.6.4. Operating business segments
9.6.5. Product portfolio
9.7. Purdue Pharma L.P.
9.7.1. Company overview
9.7.2. Key Executives
9.7.3. Company snapshot
9.7.4. Operating business segments
9.7.5. Product portfolio
9.8. Sorrento Therapeutics Inc.
9.8.1. Company overview
9.8.2. Key Executives
9.8.3. Company snapshot
9.8.4. Operating business segments
9.8.5. Product portfolio
9.8.6. Key strategic moves and developments
9.9. Amneal Pharmaceuticals LLC
9.9.1. Company overview
9.9.2. Key Executives
9.9.3. Company snapshot
9.9.4. Operating business segments
9.9.5. Product portfolio
9.9.6. Business performance
9.9.7. Key strategic moves and developments
9.10. Grunenthal
9.10.1. Company overview
9.10.2. Key Executives
9.10.3. Company snapshot
9.10.4. Operating business segments
9.10.5. Product portfolio
9.10.6. Business performance
9.10.7. Key strategic moves and developments

LIST OF TABLES
TABLE 01. GLOBAL PAIN PATCH MARKET, BY PRODUCT TYPE, 2021-2031 ($MILLION)
TABLE 02. PAIN PATCH MARKET FOR NON-OPIOID PATCHES, BY REGION, 2021-2031 ($MILLION)
TABLE 03. GLOBAL NON-OPIOID PATCHES PAIN PATCH MARKET, BY DRUGS, 2021-2031 ($MILLION)
TABLE 04. PAIN PATCH MARKET FOR OPIOID PATCHES, BY REGION, 2021-2031 ($MILLION)
TABLE 05. GLOBAL OPIOID PATCHES PAIN PATCH MARKET, BY DRUGS, 2021-2031 ($MILLION)
TABLE 06. GLOBAL PAIN PATCH MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 07. PAIN PATCH MARKET FOR PRESCRIPTION MEDICINES, BY REGION, 2021-2031 ($MILLION)
TABLE 08. PAIN PATCH MARKET FOR OTC MEDICINES, BY REGION, 2021-2031 ($MILLION)
TABLE 09. GLOBAL PAIN PATCH MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
TABLE 10. PAIN PATCH MARKET FOR HOSPITAL PHARMACIES, BY REGION, 2021-2031 ($MILLION)
TABLE 11. PAIN PATCH MARKET FOR DRUG STORES AND RETAIL PHARMACIES, BY REGION, 2021-2031 ($MILLION)
TABLE 12. PAIN PATCH MARKET FOR ONLINE PROVIDERS, BY REGION, 2021-2031 ($MILLION)
TABLE 13. PAIN PATCH MARKET, BY REGION, 2021-2031 ($MILLION)
TABLE 14. NORTH AMERICA PAIN PATCH MARKET, BY PRODUCT TYPE, 2021-2031 ($MILLION)
TABLE 15. NORTH AMERICA PAIN PATCH MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 16. NORTH AMERICA PAIN PATCH MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
TABLE 17. NORTH AMERICA PAIN PATCH MARKET, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 18. U.S. PAIN PATCH MARKET, BY PRODUCT TYPE, 2021-2031 ($MILLION)
TABLE 19. U.S. PAIN PATCH MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 20. U.S. PAIN PATCH MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
TABLE 21. CANADA PAIN PATCH MARKET, BY PRODUCT TYPE, 2021-2031 ($MILLION)
TABLE 22. CANADA PAIN PATCH MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 23. CANADA PAIN PATCH MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
TABLE 24. MEXICO PAIN PATCH MARKET, BY PRODUCT TYPE, 2021-2031 ($MILLION)
TABLE 25. MEXICO PAIN PATCH MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 26. MEXICO PAIN PATCH MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
TABLE 27. EUROPE PAIN PATCH MARKET, BY PRODUCT TYPE, 2021-2031 ($MILLION)
TABLE 28. EUROPE PAIN PATCH MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 29. EUROPE PAIN PATCH MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
TABLE 30. EUROPE PAIN PATCH MARKET, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 31. GERMANY PAIN PATCH MARKET, BY PRODUCT TYPE, 2021-2031 ($MILLION)
TABLE 32. GERMANY PAIN PATCH MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 33. GERMANY PAIN PATCH MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
TABLE 34. FRANCE PAIN PATCH MARKET, BY PRODUCT TYPE, 2021-2031 ($MILLION)
TABLE 35. FRANCE PAIN PATCH MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 36. FRANCE PAIN PATCH MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
TABLE 37. UK PAIN PATCH MARKET, BY PRODUCT TYPE, 2021-2031 ($MILLION)
TABLE 38. UK PAIN PATCH MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 39. UK PAIN PATCH MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
TABLE 40. ITALY PAIN PATCH MARKET, BY PRODUCT TYPE, 2021-2031 ($MILLION)
TABLE 41. ITALY PAIN PATCH MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 42. ITALY PAIN PATCH MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
TABLE 43. SPAIN PAIN PATCH MARKET, BY PRODUCT TYPE, 2021-2031 ($MILLION)
TABLE 44. SPAIN PAIN PATCH MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 45. SPAIN PAIN PATCH MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
TABLE 46. REST OF EUROPE PAIN PATCH MARKET, BY PRODUCT TYPE, 2021-2031 ($MILLION)
TABLE 47. REST OF EUROPE PAIN PATCH MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 48. REST OF EUROPE PAIN PATCH MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
TABLE 49. ASIA-PACIFIC PAIN PATCH MARKET, BY PRODUCT TYPE, 2021-2031 ($MILLION)
TABLE 50. ASIA-PACIFIC PAIN PATCH MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 51. ASIA-PACIFIC PAIN PATCH MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
TABLE 52. ASIA-PACIFIC PAIN PATCH MARKET, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 53. JAPAN PAIN PATCH MARKET, BY PRODUCT TYPE, 2021-2031 ($MILLION)
TABLE 54. JAPAN PAIN PATCH MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 55. JAPAN PAIN PATCH MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
TABLE 56. CHINA PAIN PATCH MARKET, BY PRODUCT TYPE, 2021-2031 ($MILLION)
TABLE 57. CHINA PAIN PATCH MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 58. CHINA PAIN PATCH MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
TABLE 59. INDIA PAIN PATCH MARKET, BY PRODUCT TYPE, 2021-2031 ($MILLION)
TABLE 60. INDIA PAIN PATCH MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 61. INDIA PAIN PATCH MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
TABLE 62. AUSTRALIA PAIN PATCH MARKET, BY PRODUCT TYPE, 2021-2031 ($MILLION)
TABLE 63. AUSTRALIA PAIN PATCH MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 64. AUSTRALIA PAIN PATCH MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
TABLE 65. SOUTH KOREA PAIN PATCH MARKET, BY PRODUCT TYPE, 2021-2031 ($MILLION)
TABLE 66. SOUTH KOREA PAIN PATCH MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 67. SOUTH KOREA PAIN PATCH MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
TABLE 68. REST OF ASIA-PACIFIC PAIN PATCH MARKET, BY PRODUCT TYPE, 2021-2031 ($MILLION)
TABLE 69. REST OF ASIA-PACIFIC PAIN PATCH MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 70. REST OF ASIA-PACIFIC PAIN PATCH MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
TABLE 71. LAMEA PAIN PATCH MARKET, BY PRODUCT TYPE, 2021-2031 ($MILLION)
TABLE 72. LAMEA PAIN PATCH MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 73. LAMEA PAIN PATCH MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
TABLE 74. LAMEA PAIN PATCH MARKET, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 75. BRAZIL PAIN PATCH MARKET, BY PRODUCT TYPE, 2021-2031 ($MILLION)
TABLE 76. BRAZIL PAIN PATCH MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 77. BRAZIL PAIN PATCH MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
TABLE 78. SAUDI ARABIA PAIN PATCH MARKET, BY PRODUCT TYPE, 2021-2031 ($MILLION)
TABLE 79. SAUDI ARABIA PAIN PATCH MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 80. SAUDI ARABIA PAIN PATCH MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
TABLE 81. SOUTH AFRICA PAIN PATCH MARKET, BY PRODUCT TYPE, 2021-2031 ($MILLION)
TABLE 82. SOUTH AFRICA PAIN PATCH MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 83. SOUTH AFRICA PAIN PATCH MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
TABLE 84. REST OF LAMEA PAIN PATCH MARKET, BY PRODUCT TYPE, 2021-2031 ($MILLION)
TABLE 85. REST OF LAMEA PAIN PATCH MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 86. REST OF LAMEA PAIN PATCH MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
TABLE 87. VIATRIS INC.: KEY EXECUTIVES
TABLE 88. VIATRIS INC.: COMPANY SNAPSHOT
TABLE 89. VIATRIS INC.: PRODUCT SEGMENTS
TABLE 90. VIATRIS INC.: PRODUCT PORTFOLIO
TABLE 91. JOHNSON AND JOHNSON: KEY EXECUTIVES
TABLE 92. JOHNSON AND JOHNSON: COMPANY SNAPSHOT
TABLE 93. JOHNSON AND JOHNSON: PRODUCT SEGMENTS
TABLE 94. JOHNSON AND JOHNSON: PRODUCT PORTFOLIO
TABLE 95. TEVA PHARMACEUTICAL INDUSTRIES LTD.: KEY EXECUTIVES
TABLE 96. TEVA PHARMACEUTICAL INDUSTRIES LTD.: COMPANY SNAPSHOT
TABLE 97. TEVA PHARMACEUTICAL INDUSTRIES LTD.: PRODUCT SEGMENTS
TABLE 98. TEVA PHARMACEUTICAL INDUSTRIES LTD.: PRODUCT PORTFOLIO
TABLE 99. TEVA PHARMACEUTICAL INDUSTRIES LTD.: KEY STRATERGIES
TABLE 100. HISAMITSU PHARMACEUTICAL CO.,INC.: KEY EXECUTIVES
TABLE 101. HISAMITSU PHARMACEUTICAL CO.,INC.: COMPANY SNAPSHOT
TABLE 102. HISAMITSU PHARMACEUTICAL CO.,INC.: PRODUCT SEGMENTS
TABLE 103. HISAMITSU PHARMACEUTICAL CO.,INC.: PRODUCT PORTFOLIO
TABLE 104. HISAMITSU PHARMACEUTICAL CO.,INC.: KEY STRATERGIES
TABLE 105. ENDO INTERNATIONAL PLC.: KEY EXECUTIVES
TABLE 106. ENDO INTERNATIONAL PLC.: COMPANY SNAPSHOT
TABLE 107. ENDO INTERNATIONAL PLC.: PRODUCT SEGMENTS
TABLE 108. ENDO INTERNATIONAL PLC.: PRODUCT PORTFOLIO
TABLE 109. NEXGEL ADVANCED HYDROGEL SOLUTIONS: KEY EXECUTIVES
TABLE 110. NEXGEL ADVANCED HYDROGEL SOLUTIONS: COMPANY SNAPSHOT
TABLE 111. NEXGEL ADVANCED HYDROGEL SOLUTIONS: PRODUCT SEGMENTS
TABLE 112. NEXGEL ADVANCED HYDROGEL SOLUTIONS: PRODUCT PORTFOLIO
TABLE 113. PURDUE PHARMA L.P.: KEY EXECUTIVES
TABLE 114. PURDUE PHARMA L.P.: COMPANY SNAPSHOT
TABLE 115. PURDUE PHARMA L.P.: PRODUCT SEGMENTS
TABLE 116. PURDUE PHARMA L.P.: PRODUCT PORTFOLIO
TABLE 117. SORRENTO THERAPEUTICS INC.: KEY EXECUTIVES
TABLE 118. SORRENTO THERAPEUTICS INC.: COMPANY SNAPSHOT
TABLE 119. SORRENTO THERAPEUTICS INC.: PRODUCT SEGMENTS
TABLE 120. SORRENTO THERAPEUTICS INC.: PRODUCT PORTFOLIO
TABLE 121. SORRENTO THERAPEUTICS INC.: KEY STRATERGIES
TABLE 122. AMNEAL PHARMACEUTICALS LLC: KEY EXECUTIVES
TABLE 123. AMNEAL PHARMACEUTICALS LLC: COMPANY SNAPSHOT
TABLE 124. AMNEAL PHARMACEUTICALS LLC: PRODUCT SEGMENTS
TABLE 125. AMNEAL PHARMACEUTICALS LLC: PRODUCT PORTFOLIO
TABLE 126. AMNEAL PHARMACEUTICALS LLC: KEY STRATERGIES
TABLE 127. GRUNENTHAL: KEY EXECUTIVES
TABLE 128. GRUNENTHAL: COMPANY SNAPSHOT
TABLE 129. GRUNENTHAL: PRODUCT SEGMENTS
TABLE 130. GRUNENTHAL: PRODUCT PORTFOLIO
TABLE 131. GRUNENTHAL: KEY STRATERGIES

★調査レポート[痛みパッチの世界市場2021-2031：機会分析・産業予測] (コード：ALD23JUN074)販売に関する免責事項を必ずご確認ください。
★調査レポート[痛みパッチの世界市場2021-2031：機会分析・産業予測]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • 温熱療法の世界市場2021-2031：機会分析・産業予測
  • 皮膚消毒剤の世界市場2021-2031：機会分析・産業予測
  • 点鼻薬の世界市場2021-2031：機会分析・産業予測
  • アテローム切除術機器の世界市場2021-2031：機会分析・産業予測
  • フィナステリドの世界市場2021-2031：機会分析・産業予測
  • 尿分析検査の世界市場2021-2031：機会分析・産業予測
  • 肥満介入装置の世界市場2021-2031：機会分析・産業予測
  • セントラルラボの世界市場2022-2031：機会分析・産業予測
  • 結核治療薬の世界市場2021-2031：機会分析・産業予測
  • 注射ペンの世界市場2021-2031：機会分析・産業予測

    • ◆H&Iグローバルリサーチのお客様（例）◆